Novartis to Sell $11 Billion Bonds to Fund Avidity Deal

Novartis AG is set to raise $11 billion to help fund its acquisition of Avidity Biosciences Inc., adding to a flurry of buyout-related bond sales.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top
Review Your Cart
0
Add Coupon Code
Subtotal